Figure 2.
Leukocyte production of IL-1β following stimulation with LPS (A), LTA (B), PG (C) and control PBS (D). Pre- and post- 3-week oral administration of placebo (open square) or resveratrol (closed circle) supplement are represented. There was no significant difference in IL-1β production between treatment groups over time (mean ± SD). LPS, lipopolysaccharide; LTA, lipoteichoic acid; PBS, phosphate-buffered saline; PG, peptidoglycan.